Summary
Microprocessor-controlled infusion pumps, which allow a patient to self-administer bolus doses of an analgesic to relieve pain, are becoming commonplace. While these patient-controlled analgesia (PCA) systems overcome the large interpatient variations in pharmacokinetics, they do not provide steady relief from pain since they rely on delivering a drug in small, incremental doses. To overcome this problem, the authors developed an algorithm and computer-pump system that allows patients to control their own plasma concentration of analgesic. This approach uses individually predetermined pharmacokinetic parameters to provide steady plasma opioid concentrations that can be increased or decreased by the patient in line with the need for more pain relief or fewer side effects. The control software uses a novel, recursive algorithm to compute the pump rates necessary to maintain constant plasma drug (e.g. morphine) concentrations at desired values and to reach a new steady concentration in response to patient requests. This report describes the mathematical approach to the problem of control of plasma opioid concentration, the application of this new drug delivery system to management of persistent pain in cancer patients undergoing bone marrow transplantation, and the magnitude of pharmacokinetic variability with morphine in this patient population. Results are presented from individual patients using this adjustable drug delivery system continuously for up to 2 weeks to control pain from oral mucositis.
Similar content being viewed by others
References
Akaike H. Fitting autoregressive models for prediction. Annals of the Institute of Statistical Mathematics 23: 243–247, 1969
Alvis MJ, Reves JG, Govier AV, Menkhans PG, Henling CE, et al. Computer-assisted continuous infusions of fentanyl during cardiac anesthesia: comparison to a manual method. Anesthesiology 63: 41–49, 1985
Ausems ME, Stanski DR, Hug CC. An evaluation of the accuracy of pharmacokinetic data for the computer-assisted infusion of alfentanil. British Journal of Anaesthesiology 57: 1217–1225, 1985
Austin KL, Stapleton JV, Mather LE. Relationship between blood meperidine concentration and analgesic response: a preliminary report. Anesthesiology 53: 460–466, 1980
Bauman TJ, Batenhorst RL, Graves DA, Foster TS, Bennett RL. Patient-controlled analgesia. Annals of Internal Medicine 20: 297–301, 1986
Bennett RL. Patient-controlled analgesia for the control of postoperative pain: experience at the University of Kentucky. In Harmer et al. (Eds) Patient-controlled analgesia, pp. 149–155, Blackwell Scientific Publications, Oxford 1985
Bennett RL, Batenhorst RL, Graves D, Foster TS, Griffen WO, et al. Drug use pattern in patient controlled analgesia. Anesthesiology 57: A210, 1982
Berkowitz BA, Ngai SH, Hempstead J, Spector S. The disposition of morphine in surgical patients. Clinical Pharmacology and Therapeutics 17: 629–635, 1975
Bovill JG, Sebel PS, Blackburn CL, Heykants J. The pharmacokinetics of alfentanil (R39209): a new opiate analgesic. Anesthesiology 57: 871–877, 1982
Chapko MK, Syrjala KL, Schilter L, Cummings C, Sullivan KM. Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea. Bone Marrow Transplantation 4: 181–186, 1989
Citron ML, Johnson-Early A, Boyer M, Krasnow SH, Hood M, Cohen MH. Patient-controlled analgesia for severe cancer pain. Archives of Internal Medicine 146: 734–736, 1986
Citron M, Johnston-Early A, Fossieck BE, Krasnow SH, Franklin R, et al. Safety and efficacy of continuous intravenous morphine for severe cancer pain. American Journal of Medicine 77: 199–204, 1984
Colpaert FC. Long-term suppression of pain by narcotic drugs in the absence of tolerance development. Archives Internationales de Pharmacodynamie et de Thérapie 236: 293–295, 1978
Colpaert FC, Niemegeers JE, Janssen PAJ, Maroli AN. The effects of prior fentanyl administration and of pain on fentanyl analgesia: tolerance to and enhancement of narcotic analgesia. Journal of Pharmacology and Experimental Therapeutics 213: 418–424, 1980
Coyle N, Mauskop A, Maggard J, Foley KM. Continuous subcutaneous infusions of opiates in cancer patients with pain. Oncology Nursing Forum 13: 53–57, 1986
Dahlstrom B, Tamsen A, Paalzow L, Hartvig P. Patient controlled analgesic therapy: part IV. Pharmacokinetics and analgesic plasma concentrations of morphine. Clinical Pharmacokinetics 7: 266–279, 1982
Fox JL, Lamson ML. RSTRIP: pharmacokinetic data stripping/least squares parameter optimisation, Micromath, Inc, 1986
Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed., Marcel Dekker Inc., New York, 1982
Gourlay GK, Plummer SR, Cousins MJ, Armstrong PJ. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesthesia and Analgesia 67: 329–337, 1988
Gourlay GK, Willis RJ, Lamberty J. A double-blind comparison of the efficacy of methadone and morphine in postoperative pain control. Anesthesiology 64: 322–327, 1986
Harrison MJ. Prediction of infusion rates: computer study. British Journal of Anaesthesiology 64: 283–286, 1990
Hecker BR, Albert L. Patient-controlled analgesia: a randomized, prospective comparison between two commercially available PCA pumps and conventional analgesic therapy for postoperative pain. Pain 35: 115–120, 1988
Hill HF. Pharmacokinetic tailoring of computer-controlled drug infusions. In Smith et al. (Eds) Pharmacodynamic research: current problems, potential solutions, pp. 158–166, Harvey Whitney Books, Cincinnati, 1988
Hill HF, Chapman CR. Tailored infusion of opioids. In Benedetti et al. (Eds) Advances in pain research and therapy, vol. 14, Raven Press, New York, 1989
Hill HF, Chapman CR, Kornell J, Sullivan K, Saeger L, et al. Self-administration of morphine in bone marrow transplant patients reduces drug requirement. Pain 40: 121–129, 1990a
Hill HF, Mackie AM, Coda BA. Pharmacokinetically tailored opioid infusions for patient controlled analgesia: comparison of morphine and alfentanil. Pain (Suppl. 5): S269, 1990c
Hill HF, Mackie AM, Jacobson RC. Pharmacokinetic aspects of patient-controlled analgesia. In Ferrante et al. (Eds): Recent advances in patient-controlled analgesia, pp. 214–222, Black-well Scientific Publications, Oxford, 1990b
Hill HF, Saeger LC, Bjurstrom R, Donaldson G, Jacobson RC, et al. Steady-state infusion of opioids in human volunteers: I. Pharmacokinetic tailoring. Pain, in press, 1990d
Hill HF, Saeger LC, Chapman CR. Patient-controlled analgesia after bone marrow transplantation for cancer. Postgraduate Medicine August 28: 33–40, 1986a
Hill HF, Walter M, Saeger L, Sargur M, Sizemore W, et al. Dose effects of alfentanil in human analgesia. Clinical Pharmacology and Therapeutics 40: 178–186, 1986b
Hoskin PJ, Hanks GW, Heron CW, Aherne GW, Chapman D. M6G and its analgesic action in chronic use. Clinical Journal of Pain 5: 199–201, 1989
Hull CJ. The pharmacokinetics of opioid analgesics, with special reference to patient-controlled administration. In Harmer et al. (Eds) Patient-controlled analgesia, pp. 7–17, Blackwell Scientific Publications, Oxford, 1985
Hull CJ. Opioid infusions for the management of postoperative pain. In Smith & Covino (Eds) Acute pain, pp. 155–179, Butterworths, London, 1985b
Inturrisi CE, Colburn WA. Application of pharmacokinetic-pharmacodynamic modeling to analgesia. In Foley & Inturrisi (Eds) Advances in pain research and therapy, Vol. 8, pp. 441–452, Raven Press, New York, 1986
Inturrisi CE, Portenoy RK, Max MB, Colburn WA, Foley KM. Pharmacokinetic-pharmacodynamic relationships of methadone infusion in patients with cancer pain. Clinical Pharmacology and Therapeutics 47: 565–577, 1990
Inturrisi C, Portenoy R, Stillman M, Colburn W, Foley K. Hydromorphone bioavailability and pharmacokinetic pharmacodynamic (PK-PD) relationships. Clinical Pharmacology and Therapeutics 43: 162, 1988
Kerr IG, Sone M, DeAngelis C, Iscoe N, MacKenzie R, et al. Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain to outpatients. Annals of Internal Medicine 108: 554–557, 1988
Kruger-Theimer E. Continuous intravenous infusion and multicompartmental accumulation. European Journal of Pharmacology 4: 317–324, 1968
Lehmann KA. Practical experience with demand analgesia for postoperative pain. In Harmer et al. (Eds) Patient-controlled analgesia, pp. 134–139, Blackwell Scientific Publications, Oxford 1985
Lehmann KA. Patient-controlled intravenous analgesia for postoperative pain relief: issues in study design. In Max et al. (Eds) Design of analgesic clinical trials, Raven Press, New York, in press, 1990
Martin RW, Hill HF, Yee HC, Saeger LD, Walter MH, et al. An open loop computer-based drug infusion system. IEEE Transactions on Biomedical Engineering BME 34: 158–166, 1987
Metzler CM, Weiner DL. PCNONLIN: software for the statistical analysis of nonlinear models (version 3.0), Statistical Consultants, Inc., Lexington 1989
Nimmo WS, Todd JG. Fentanyl by constant rate i.v. infusion for postoperative analgesia. British Journal of Anaesthesiology 57: 250–254, 1985
Osborne R, Joel S, Trew C, Slevin M. Morphine and metabolic behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clinical Pharmacology and Therapeutics 47: 12–19, 1990
Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist. Life Sciences 41: 2845–2849, 1987
Peterson GM, Randall CTC, Peterson J. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship of renal function and route of administration. European Journal of Clinical Pharmacology 38: 121–124, 1990
Portenoy RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM. IV infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treatment Reviews 70: 575–581, 1986
Reilly CS, Wood AJJ, Wood M. Variability of fentanyl pharmacokinetics in man. Anaesthesia 40: 837–843, 1984
Robinson JO, Rosen M, Evans JM, Revill SI, David H, et al. Self-administered intravenous and intramuscular pethidine: a controlled trial in labor. Anaesthesia 35: 763–770, 1980
Sandidge CH, Marvin JA, Heimbach DM. Patient controlled analgesia (PCA) in treating pain in burn patients. 19th Annual Burn Association Meeting Proceedings, A46, 1987
Stanski DR, Greenblatt DJ, Lowenstein E. Kinetics of intravenous and intramuscular morphine. Clinical Pharmacology and Therapeutics 24: 52–59, 1978
Tamsen A, Hartvig P, Fagerlund C, Dahlstrom B. Patient-controlled analgesic therapy: part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain. Clinical Pharmacokinetics 7: 164–175, 1982
Todd RD, Muldoon SM, Watson RL. Determination of morphine in cerebrospinal fluid and plasma by high performance liquid chromatography with electrochemical detection. Journal of Chromatography and Biomedical Applications 232: 101–110, 1982
Vaughan DP, Tucker GT. General derivation of the ideal drug input required to achieve and maintain constant plasma drug concentration: theoretical application to lignocaine therapy. European Journal of Clinical Pharmacology 10: 433–440, 1976
Vickers MD. Clinical trials of analgesic drugs. In Harmer et al. (Eds) Patient controlled analgesia, Blackwell Scientific Publications, Oxford, 1985
White PF. Use of a patient-controlled analgesia infuser for the management of postoperative pain. In Harmer et al. (Eds) Patient-controlled analgesia, pp. 140–148, Blackwell Scientific Publications, Oxford, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hill, H.F., Jacobson, R.C., Coda, B.A. et al. A Computer-Based System for Controlling Plasma Opioid Concentration According to Patient Need for Analgesia. Clin. Pharmacokinet. 20, 319–330 (1991). https://doi.org/10.2165/00003088-199120040-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199120040-00006